Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2476 AL 2490

[Effects of the induction of anesthesia with propofol on hemodynamics in patients with Parkinson's disease]

Nakajima R, Kato J, Iwasaki K, Ogawa Y, Gokan D, Ogawa S.

Masui. 2011 Oct;60(10):1135-43.

Can nicotine be used medicinally in Parkinson's disease?

Thiriez C, Villafane G, Grapin F, Fenelon G, Remy P, Cesaro P.

Expert Rev Clin Pharmacol. 2011 Jul;4(4):429-36. doi: 10.1586/ecp.11.27.

Therapeutic potential of new hydrogen sulfide-releasing hybrids

Sparatore A, Santus G, Giustarini D, Rossi R, Del Soldato P.

Expert Rev Clin Pharmacol. 2011 Jan;4(1):109-21. doi: 10.1586/ecp.10.122.

Spotlight on rotigotine transdermal patch in Parkinson's disease

Sanford M, Scott LJ.

Drugs Aging. 2011 Dec 1;28(12):1015-7. doi: 10.2165/11207780-000000000-00000.

L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease

Navailles S, Carta M, Guthrie M, De Deurwaerdère P.

Cent Nerv Syst Agents Med Chem. 2011 Dec 1;11(4):305-20. doi: 10.2174/1871524911106040305.

Vascular parkinsonism: what makes it different?

Gupta D, Kuruvilla A.

Postgrad Med J. 2011 Dec;87(1034):829-36. doi: 10.1136/postgradmedj-2011-130051.

Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson's Disease in a Patient with HIV Infection: Dual Clinical Benefit

Gago MF, Rosas MJ, Linhares P, Massano J, Sarmento A, Vaz R.

Case Rep Neurol. 2011 Sep;3(3):219-22. doi: 10.1159/000332610. Epub 2011 Sep 20.

Clozapine safety, 35 years later

Raja M.

Curr Drug Saf. 2011 Jul;6(3):164-84. doi: 10.2174/157488611797579230.

The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial

Daley DJ, Deane KH, Gray RJ, Worth PF, Clark AB, Sabanathan K, Pfeil M, Myint PK.

Trials. 2011 Nov 28;12:251. doi: 10.1186/1745-6215-12-251.

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia

Larsson V, Engedal K, Aarsland D, Wattmo C, Minthon L, Londos E.

Dement Geriatr Cogn Disord. 2011;32(4):227-34. doi: 10.1159/000334523. Epub 2011 Nov 25.

Manganese and Parkinson's disease: a critical review and new findings

Guilarte TR.

Cien Saude Colet. 2011 Nov;16(11):4549-66. doi: 10.1590/s1413-81232011001200028.

Serotonergic dysfunction in Parkinson's disease and its relevance to disability

Politis M, Loane C.

ScientificWorldJournal. 2011;11:1726-34. doi: 10.1100/2011/172893. Epub 2011 Oct 17.

Interaction between α-synuclein and other proteins in neurodegenerative disorders

Jellinger KA.

ScientificWorldJournal. 2011;11:1893-907. doi: 10.1100/2011/371893. Epub 2011 Oct 24.

Just noticeable difference in olfaction: a discriminative tool between healthy elderly and patients with cognitive disorders associated with dementia

Hidalgo J, Chopard G, Galmiche J, Jacquot L, Brand G.

Rhinology. 2011 Dec;49(5):513-8. doi: 10.4193/Rhino11.013.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias